Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine是溴氰菊酯在体外被原核蛋白(如CYP6A14和CYP6N6)复合物主要代谢产生的降解产物。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | γ-Oleoyl-β-stearoyl-L-α-glycerophosphoryl-aethanolamin | 3927-73-9 | C41H80NO8P | 746.062 |
二油酰基 L-α-磷脂酰乙醇胺 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 4004-05-1 | C41H78NO8P | 744.046 |
—— | 2-azaniumylethyl (2R)-2-(hexadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphate | —— | C39H76NO8P | 718.0 |
—— | L-(+)-2-Linoleoyl-3-oleoyl-glycerin-1-phosphorsaeure-(2-amino-aethylester) | 1188-56-3 | C41H76NO8P | 742.03 |
—— | (9Z)-9-octadecenoate-(2’S)-2’,3’-dihydroxypropyl ester | 34487-30-4 | C21H40O4 | 356.546 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
二油酰基 L-α-磷脂酰乙醇胺 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 4004-05-1 | C41H78NO8P | 744.046 |
—— | 2-azaniumylethyl (2R)-2-(hexadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphate | —— | C39H76NO8P | 718.0 |
—— | L-(+)-2-Linoleoyl-3-oleoyl-glycerin-1-phosphorsaeure-(2-amino-aethylester) | 1188-56-3 | C41H76NO8P | 742.03 |
—— | (2E,4E)-16-Methyl-octadeca-2,4-dienoic acid (R)-2-[(2-amino-ethoxy)-hydroxy-phosphoryloxy]-1-((Z)-octadec-9-enoyloxymethyl)-ethyl ester | 198624-43-0 | C42H78NO8P | 756.057 |
L-ALPHA-甘油磷酰乙醇胺 | sn-glycero-3-phosphoethanolamine | 33049-08-0 | C5H14NO6P | 215.143 |
All organisms consist of cells that are enclosed by a cell membrane containing bipolar lipids and proteins. Glycerophospholipids are important not only as structural and functional components of cellular membrane but also as precursors of various lipid mediators. Polyunsaturated fatty acids comprising arachidonic acid or eicosapentaenoic acid are located at
Advances in human genetics are leading to the discovery of new disease-causing mutations at a remarkable rate. Many such mutations, however, occur in genes that encode for proteins of unknown function, which limits our molecular understanding of, and ability to devise treatments for, human disease. Here, we use untargeted metabolomics combined with a genetic mouse model to determine that the poorly characterized serine hydrolase α/β-hydrolase domain-containing (ABHD)12, mutations in which cause the human neurodegenerative disorder PHARC (polyneuropathy, hearing loss, ataxia, retinosis pigmentosa, and cataract), is a principal lysophosphatidylserine (LPS) lipase in the mammalian brain. ABHD12 −/− mice display massive increases in a rare set of very long chain LPS lipids that have been previously reported as Toll-like receptor 2 activators. We confirm that recombinant ABHD12 protein exhibits robust LPS lipase activity, which is also substantially reduced in ABHD12 −/− brain tissue. Notably, elevations in brain LPS lipids in ABHD12 −/− mice occur early in life (2–6 mo) and are followed by age-dependent increases in microglial activation and auditory and motor defects that resemble the behavioral phenotypes of human PHARC patients. Taken together, our data provide a molecular model for PHARC, where disruption of ABHD12 causes deregulated LPS metabolism and the accumulation of proinflammatory lipids that promote microglial and neurobehavioral abnormalities.